SGCM
AGN

Sand Grove Capital Management’s Allergan plc AGN Stock Holding History

Sand Grove Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-265,000
Closed -$44.3M – 16
2019
Q2 		$44.3M Buy
+265,000
New +$36.7M 4.72% 8

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sand Grove Capital Management's AGN Position: Q3 2019 in Review

Sand Grove Capital Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 265,000 shares — an estimated $44.3M sold.

Sand Grove Capital Management first reported a position in AGN in Q2 2019 and held it in 1 quarter. The position peaked at $44.3M in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Sand Grove Capital Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Sand Grove Capital Management sold 265,000 Allergan plc shares in Q3 2019, an estimated $44.3M.
  • Sand Grove Capital Management first reported a position in Allergan plc in Q2 2019 and held it in 1 quarter.
  • Sand Grove Capital Management's Allergan plc position peaked at $44.3M in Q2 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Sand Grove Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.